valproic acid has been researched along with resveratrol in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (8.33) | 29.6817 |
| 2010's | 13 (54.17) | 24.3611 |
| 2020's | 9 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Dansette, PM; Fontana, E; Poli, SM | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Forgione, M; Hailu, GS; Mai, A; Robaa, D; Rotili, D; Sippl, W | 1 |
| Alfano, AI; Barone, S; Brindisi, M; Cassese, E; Summa, V | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Gray, SG | 1 |
| Chen, KC; Hsieh, CL; Lin, PX; Peng, CC; Peng, RY | 1 |
| Alka, K; Dolly, JO; Henehan, GT; Ryan, BJ | 1 |
| Bambini-Junior, V; Della Flora Nunes, G; Fontes-Dutra, M; Gottfried, C; Michels, M; Mueller de Melo, G; Nogueira Freire, V; Riesgo, R; Zanatta, G | 1 |
| Chen, Y; Hsieh, CL; Lin, PX; Peng, CC; Peng, RY | 1 |
| Fuentes, JM; Gómez-Sánchez, R; González-Polo, RA; Pedro, JM; Pizarro-Estrella, E; Rodríguez-Arribas, M; Yakhine-Diop, SM | 1 |
| Chen, H; Chen, J; Hardin, H; Harrison, AD; Larrain, C; Lloyd, RV; Yu, XM; Zhang, R | 1 |
| Glasow, A; Kortmann, RD; Menzel, F; Patties, I | 1 |
| Baldisserotto, B; Barreto, KP; Finamor, IA; Glanzner, WG; Gonçalves, PB; Ourique, GM; Pavanato, MA; Pês, TS; Saccol, EM | 1 |
| Annunziato, L; Benarese, M; Cepparulo, P; Cuomo, O; Faggi, L; Lanzillotta, A; Mota, M; Parrella, E; Pignataro, G; Pizzi, M; Porrini, V; Spano, P; Tonin, P; Vinciguerra, A | 1 |
| Bambini-Junior, V; Bauer-Negrini, G; Deckmann, I; Della-Flora Nunes, G; Fontes-Dutra, M; Gottfried, C; Hirsch, MM; Margis, R; Nunes, W; Rabelo, B; Riesgo, R | 1 |
| Bambini-Junior, V; Bauer-Negrini, G; Della-Flora Nunes, G; Fontes-Dutra, M; Gottfried, C; Green, L; Hirsch, MM; Riesgo, R; Santos-Terra, J; Souza-Nunes, W | 1 |
| Bambery, KR; Karagiannis, TC; Licciardi, PV; Mazarakis, N; Royce, SG; Samuel, CS; Snibson, KJ; Tobin, MJ; Ververis, K; Vongsvivut, J | 1 |
| Bambini-Junior, V; Deckmann, I; Fontes-Dutra, M; Gama, CS; Gottfried, C; Paz, AVC; Santos-Terra, J; Schwingel, GB | 1 |
| Chung, RS; Cole, NJ; De Luca, A; Guillemin, GJ; Laird, AS; Lee, A; Luu, L; Nicholson, GA; Robinson, KJ; Suddull, HJ; Tym, MC; Watchon, M; Yuan, KC | 1 |
| Bankole, O; Bonafede, R; Mariotti, R; Muccilli, M; Parrella, E; Pizzi, M; Scambi, I; Turano, E | 1 |
| Bauer-Negrini, G; Carello-Collar, G; Deckmann, I; Fontes-Dutra, M; Gottfried, C; Nunes, GD; Riesgo, R; Santos-Terra, J; Schwingel, GB | 1 |
| Brum Schwingel, G; Calcagnotto, ME; Deckmann, I; Fontes-Dutra, M; Gottfried, C; Kazmierzak de Moraes, R; Rabelo, B; Righes Marafiga, J; Rockenbach, M; Santos-Terra, J; Vendramin Pasquetti, M | 1 |
| Amiresmaili, S; Bashiri, H; Juybari, KB; Moslemizadeh, A; Sepehri, G; Shahrbabaki, SSV; Shamsi Meymandi, M; Tezerji, SS | 1 |
5 review(s) available for valproic acid and resveratrol
| Article | Year |
|---|---|
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic | 2005 |
Lysine Deacetylase Inhibitors in Parasites: Past, Present, and Future Perspectives.
Topics: Animals; Antiparasitic Agents; Drug Repositioning; Helminth Proteins; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Leishmania; Plasmodium; Protozoan Proteins; Schistosoma; Toxoplasma; Trypanosoma | 2017 |
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.
Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Histone Deacetylase 6; Humans; Signal Transduction | 2022 |
Epigenetic treatment of neurological disease.
Topics: Alzheimer Disease; Butylamines; Cell Differentiation; Endoplasmic Reticulum Stress; Epigenesis, Genetic; Histone Code; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Huntington Disease; Hydroxamic Acids; Neurons; Phenylbutyrates; Protein Processing, Post-Translational; Resveratrol; Stilbenes; Valproic Acid; Vorinostat | 2011 |
Is the Modulation of Autophagy the Future in the Treatment of Neurodegenerative Diseases?
Topics: Animals; Autophagy; Disease Models, Animal; Food; Humans; Isothiocyanates; Lithium; Neurodegenerative Diseases; Resveratrol; Sirolimus; Spermidine; Stilbenes; Sulfoxides; Trehalose; Valproic Acid | 2015 |
19 other study(ies) available for valproic acid and resveratrol
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Resveratrol and vitamin E rescue valproic acid-induced teratogenicity: the mechanism of action.
Topics: Abnormalities, Drug-Induced; Animals; Antioxidants; Chick Embryo; Glutathione; Reactive Oxygen Species; Resveratrol; Stilbenes; Teratogenesis; Valproic Acid; Vitamin E | 2014 |
New inhibitors of the Kvβ2 subunit from mammalian Kv1 potassium channels.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Binding, Competitive; Brain; Catechols; Cortisone; Kinetics; NADP; Oxidation-Reduction; Potassium Channel Blockers; Potassium Channels, Voltage-Gated; Protein Binding; Rats; Resveratrol; Rutin; Shaker Superfamily of Potassium Channels; Stilbenes; Valproic Acid | 2014 |
Resveratrol prevents social deficits in animal model of autism induced by valproic acid.
Topics: Animals; Anti-Inflammatory Agents; Autistic Disorder; Female; Male; Maternal Exposure; Molecular Dynamics Simulation; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Wistar; Resveratrol; Social Skills; Stilbenes; Valproic Acid | 2014 |
The proteomic and genomic teratogenicity elicited by valproic acid is preventable with resveratrol and α-tocopherol.
Topics: alpha-Tocopherol; Animals; Anticonvulsants; Betaine-Homocysteine S-Methyltransferase; Carrier Proteins; Chick Embryo; Chromatography, Liquid; Filamins; Gene Expression Regulation; Membrane Proteins; Myosin Light Chains; Phosphatidylethanolamine Binding Protein; Proteome; Resveratrol; Serum Albumin; Stilbenes; Tandem Mass Spectrometry; Teratogens; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Valproic Acid | 2014 |
Generation of Novel Thyroid Cancer Stem-Like Cell Clones: Effects of Resveratrol and Valproic Acid.
Topics: Animals; Antioxidants; Blotting, Western; Cell Culture Techniques; Cell Line, Tumor; Enzyme Inhibitors; Flow Cytometry; Heterografts; Humans; Mice; Mice, Nude; Neoplastic Stem Cells; Real-Time Polymerase Chain Reaction; Resveratrol; Stilbenes; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Valproic Acid | 2016 |
Enhanced inhibition of clonogenic survival of human medulloblastoma cells by multimodal treatment with ionizing irradiation, epigenetic modifiers, and differentiation-inducing drugs.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cerebellar Neoplasms; Combined Modality Therapy; Decitabine; Dideoxynucleosides; Epigenesis, Genetic; Humans; Hydroxamic Acids; Medulloblastoma; Mice; Neurogenesis; Radiation-Sensitizing Agents; Resveratrol; Stilbenes; Treatment Outcome; Tretinoin; Valproic Acid; Vorinostat; Xenograft Model Antitumor Assays | 2016 |
Resveratrol prevents oxidative damage and loss of sperm motility induced by long-term treatment with valproic acid in Wistar rats.
Topics: Animals; Anticonvulsants; Antioxidants; Fertility; Genitalia, Male; Male; Oxidative Stress; Rats, Wistar; Resveratrol; Sperm Motility; Spermatozoa; Stilbenes; Testosterone; Valproic Acid | 2016 |
Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke.
Topics: Acetylation; Animals; Bcl-2-Like Protein 11; Disease Models, Animal; Drug Synergism; Histone Deacetylase Inhibitors; Histones; Male; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Promoter Regions, Genetic; Protein Binding; Resveratrol; Stilbenes; Stroke; Transcription Factor RelA; Valproic Acid | 2018 |
Behavioral alterations in autism model induced by valproic acid and translational analysis of circulating microRNA.
Topics: Adolescent; Animals; Anticonvulsants; Antioxidants; Autistic Disorder; Behavior, Animal; Child; Child, Preschool; Circulating MicroRNA; Disease Models, Animal; Female; Humans; Male; Maternal Exposure; MicroRNAs; Pregnancy; Prenatal Exposure Delayed Effects; Protein Biosynthesis; Rats, Wistar; Resveratrol; Stilbenes; Valproic Acid | 2018 |
Abnormal empathy-like pro-social behaviour in the valproic acid model of autism spectrum disorder.
Topics: Animals; Autism Spectrum Disorder; Disease Models, Animal; Empathy; Female; Interpersonal Relations; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Resveratrol; Social Behavior; Valproic Acid | 2019 |
Investigation of molecular mechanisms of experimental compounds in murine models of chronic allergic airways disease using synchrotron Fourier-transform infrared microspectroscopy.
Topics: Animals; Anti-Asthmatic Agents; Asthma; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Hydroxamic Acids; Isothiocyanates; Mice; Mice, Inbred BALB C; Ovalbumin; Relaxin; Resveratrol; Spectroscopy, Fourier Transform Infrared; Sulfoxides; Synchrotrons; Treatment Outcome; Valproic Acid | 2020 |
Resveratrol prevents long-term structural hippocampal alterations and modulates interneuron organization in an animal model of ASD.
Topics: Animals; Autism Spectrum Disorder; Behavior, Animal; Disease Models, Animal; Female; Hippocampus; Interneurons; Male; Neurons; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Wistar; Resveratrol; Social Behavior; Stereotyped Behavior; Valproic Acid | 2021 |
Sodium valproate increases activity of the sirtuin pathway resulting in beneficial effects for spinocerebellar ataxia-3 in vivo.
Topics: Acetylation; Animals; Animals, Genetically Modified; Ataxin-3; Autophagy; Carbazoles; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Synergism; Genes, Reporter; HEK293 Cells; Histone Deacetylase Inhibitors; Histones; Humans; Machado-Joseph Disease; Peptides; Protein Processing, Post-Translational; Recombinant Fusion Proteins; Repressor Proteins; Resveratrol; Signal Transduction; Sirtuin 1; Sirtuins; Swimming; Trinucleotide Repeat Expansion; Valproic Acid; Zebrafish; Zebrafish Proteins | 2021 |
Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice.
Topics: AMP-Activated Protein Kinases; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Female; Histone Deacetylase Inhibitors; Histones; Male; Mice; Mice, Transgenic; NF-kappa B; Resveratrol; Sirtuin 1; Superoxide Dismutase; Valproic Acid | 2022 |
Resveratrol Prevents Cytoarchitectural and Interneuronal Alterations in the Valproic Acid Rat Model of Autism.
Topics: Animals; Autism Spectrum Disorder; Autistic Disorder; Disease Models, Animal; Female; Interneurons; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Resveratrol; Valproic Acid | 2022 |
GABAergic synaptic transmission and cortical oscillation patterns in the primary somatosensory area of a valproic acid rat model of autism spectrum disorder.
Topics: Animals; Autism Spectrum Disorder; Behavior, Animal; Disease Models, Animal; Female; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Resveratrol; Rodentia; Social Behavior; Somatosensory Cortex; Synaptic Transmission; Valproic Acid | 2023 |
Ameliorating age-dependent effects of resveratrol on VPA-induced social impairments and anxiety-like behaviors in a rat model of neurodevelopmental disorder.
Topics: Animals; Anxiety; Autism Spectrum Disorder; Behavior, Animal; Disease Models, Animal; Female; Humans; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Resveratrol; Social Behavior; Valproic Acid | 2023 |